Concepedia
Statistics
Publications
8
Citations
541
H-Index
Active since
2001
Affiliations
Samsung Medical Center(Current)
Sungkyunkwan University
Taipei Veterans General Hospital
Roche (United Kingdom)
Koo Foundation Sun Yat-Sen Cancer Center
Y-H Im is an author at Samsung Medical Center specializing in medicine, oncology, and pharmacology.
Publications per year
2001–2022
Loss of transforming growth factor β signalling in the intestine contributes to tissue injury in inflammatory bowel disease
Hahm Kb, Y-H Im, W. Tony Parks et al. · Gut · 2001 · 193 citations · Full text
Life Sciences, Immunology, Molecular Biology +17
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
Hope S. Rugo, Joyce O’Shaughnessy, F Boyle et al. · Annals of Oncology · 2022 · 128 citations · Full text
Medicine, Oncology, Pharmacology +16
Abstract S3-2: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Antitumor and Safety Analysis of a Randomized Phase II Study ('NeoSphere')
Luca Gianni, Tadeusz Pieńkowski, Y-H Im et al. · Cancer Research · 2010 · 67 citations
Medicine, Oncology, Pharmacology +17
Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer
S T Kim, Wonseok Kang, Joon Ho Kang et al. · British Journal of Cancer · 2005 · 62 citations · Full text
S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).
Luca Gianni, Giampaolo Bianchini, Astrid Kiermaier et al. · Cancer Research · 2011 · 49 citations
Medicine, Molecular Medicine, Oncology +17
1–5 of 8